Clarius Group’s NGM Biopharmaceuticals NGM Stock Holding History
Bought
Maintained
Sold
Clarius Group's NGM Position: Q2 2024 in Review
Clarius Group sold out of NGM Biopharmaceuticals (NGM) in Q2 2024, closing a stake of 26,912 shares — an estimated $42.8K sold.
Clarius Group first reported a position in NGM in Q4 2023 and held it in 2 quarters. The position peaked at $42.8K in Q1 2024. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.
- Clarius Group reported no remaining NGM Biopharmaceuticals position as of Q2 2024 after selling out during the quarter.
- Clarius Group sold 26,912 NGM Biopharmaceuticals shares in Q2 2024, an estimated $42.8K.
- Clarius Group first reported a position in NGM Biopharmaceuticals in Q4 2023 and held it in 2 quarters.
- Clarius Group's NGM Biopharmaceuticals position peaked at $42.8K in Q1 2024.
- 0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals as of Q2 2024.
Based on Clarius Group's 13F filing for Q2 2024, filed 11 Jul 2024.